House Bill 7537
116th Congress(2019-2020)
Infectious Disease Therapies Research and Innovation Act of 2020
Introduced
Introduced in House on Jul 9, 2020
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
7537
Congress
116
Policy Area
Taxation
Taxation
Primary focus of measure is all aspects of income, excise, property, inheritance, and employment taxes; tax administration and collection. Measures concerning state and local finance may fall under Economics and Public Finance policy area.
No House votes have been held for this bill.
Summary
Infectious Disease Therapies Research and Innovation Act of 2020
This bill exempts from the definition of passive activity, for purposes of the passive loss tax rules, any qualified medical research activity of a specified medical research small business pass-thru entity.
The bill defines specified medical research small business pass-thru entity as any domestic pass-thru entity if more than 80% of such entity's expenditures on research are paid or incurred in connection with qualified medical research activities and the gross receipts of such entity for the taxable year are less than $1 million.
July 9, 2020
Sort by most recent
07/09/2020
Referred to the House Committee on Ways and Means.
07/09/2020
Referred to the Subcommittee on Health.
07/09/2020
Introduced in House
Public Record
Record Updated
Jan 11, 2023 1:45:59 PM